12.08.2016 • NewsElaine BurridgeSumitomoZeon

Sumitomo and Zeon Study Rubber Merger

Japanese firms Sumitomo Chemical and Zeon Corporation have agreed to study a possible consolidation of their solution styrene-butadiene rubber (S-SBR) businesses. While this agreement is not legally binding, both companies will discuss and agree the details of a potential merger. The plan is to form a new joint venture company which will comprise their current S-SBR operations and those of their respective subsidiaries.

The aim is to strengthen the business by accelerating new product development, enhancing cost competitiveness and securing stable supply. Legally binding definitive agreements will be signed after Sumitomo Chemical and Zeon have completed their internal authorization procedures. At the same time, steps will be taken to obtain the necessary regulatory approvals or clearance of the deal both in Japan and overseas.

The current schedule envisages completing due diligence and studies by the end of next month, with definitive agreements signed by the end of December. It is anticipated that the new company will be formed in April 2017.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read